These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 25003684

  • 21. [Combined hepatocellular and cholangiocarcinoma].
    Omagari K, Makiyama K, Ikuno N.
    Ryoikibetsu Shokogun Shirizu; 1995; (7):473-5. PubMed ID: 8749529
    [No Abstract] [Full Text] [Related]

  • 22. [Long-Term Survival in a Patient with Combined Hepatocellular-Cholangiocarcinoma Treated with Multidisciplinary Therapy - A Case Report].
    Okubo Y, Tono T, Kawasaki Y, Ishii T, Hara H, Senba S, Yasuda S, Otsuru M.
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1065-1067. PubMed ID: 29394535
    [Abstract] [Full Text] [Related]

  • 23. Current role of portal vein embolization/hepatic artery chemoembolization.
    Kokudo N, Makuuchi M.
    Surg Clin North Am; 2004 Apr; 84(2):643-57. PubMed ID: 15062666
    [Abstract] [Full Text] [Related]

  • 24. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
    Wu C, Bai DS, Jiang GQ, Jin SJ.
    World J Surg Oncol; 2014 Nov 10; 12():337. PubMed ID: 25385169
    [Abstract] [Full Text] [Related]

  • 25. Hepatocellular carcinoma and cholangiocarcinoma: an update.
    Yazici C, Niemeyer DJ, Iannitti DA, Russo MW.
    Expert Rev Gastroenterol Hepatol; 2014 Jan 10; 8(1):63-82. PubMed ID: 24245910
    [Abstract] [Full Text] [Related]

  • 26. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
    Furuta T, Kanematsu T, Sonoda T, Sugimachi K.
    Eur J Surg Oncol; 1987 Feb 10; 13(1):69-73. PubMed ID: 3028868
    [Abstract] [Full Text] [Related]

  • 27. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.
    Hu J, Yuan R, Huang C, Shao J, Zou S, Wang K.
    World J Surg Oncol; 2016 Aug 17; 14(1):218. PubMed ID: 27535234
    [Abstract] [Full Text] [Related]

  • 28. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
    Maeda Y, Nishida M, Mori N, Tamesa T, Okada T, Tangoku A, Oka M.
    Nihon Rinsho; 2001 Oct 17; 59 Suppl 6():401-5. PubMed ID: 11761981
    [No Abstract] [Full Text] [Related]

  • 29. Management of combined hepatocellular and cholangiocarcinoma.
    Kassahun WT, Hauss J.
    Int J Clin Pract; 2008 Aug 17; 62(8):1271-8. PubMed ID: 18284443
    [Abstract] [Full Text] [Related]

  • 30. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M, Ariizumi S, Otsubo T, Katsuragawa H, Katagiri S, Nakano M, Takasaki K.
    J Surg Oncol; 2004 Aug 01; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [Abstract] [Full Text] [Related]

  • 31. A case of metachronous cholangiocellular and hepatocellular carcinoma with good prognosis.
    Kosone T, Takagi H, Hamada T, Kakizaki S, Takehara K, Ohwada S, Mori M.
    Hepatogastroenterology; 2005 Aug 01; 52(64):1228-32. PubMed ID: 16001668
    [Abstract] [Full Text] [Related]

  • 32. Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case.
    Sperling J, Justinger C, Schuld J, Ziemann C, Seidel R, Kollmar O.
    World J Surg Oncol; 2014 Jul 01; 12():198. PubMed ID: 24980217
    [Abstract] [Full Text] [Related]

  • 33. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.
    Brown ZJ, Hewitt DB, Pawlik TM.
    Front Biosci (Landmark Ed); 2022 Mar 05; 27(3):85. PubMed ID: 35345317
    [Abstract] [Full Text] [Related]

  • 34. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
    Lee CH, Hsieh SY, Chang CJ, Lin YJ.
    J Gastroenterol Hepatol; 2013 Jan 05; 28(1):122-7. PubMed ID: 23034166
    [Abstract] [Full Text] [Related]

  • 35. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M.
    J Gastroenterol Hepatol; 2006 May 05; 21(5):869-73. PubMed ID: 16704538
    [Abstract] [Full Text] [Related]

  • 36. [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Chen Y, Wang ZM, Ren ZG, Le F, Zhang BH, Xia JL, Ye SL, Tang ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr 05; 14(4):299-300. PubMed ID: 16635306
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
    Dong H, Cong WL, Zhu ZZ, Wang B, Xian ZH, Yu H.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 05; 30(9):702-5. PubMed ID: 19173916
    [Abstract] [Full Text] [Related]

  • 39. [Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
    Niinobu T, Shibata T, Fukushima Y, Kitada M, Tukahara Y, Hata S, Ikeda K, Hayashida H, Fuzita J, Takahashi Y, Nakamura T, Suzuki R, Shimano T, Takami M, Ishida T.
    Gan To Kagaku Ryoho; 2000 Oct 05; 27(12):1931-5. PubMed ID: 11086448
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic approach to hepatocellular carcinoma: a difficult choice.
    Gennari L.
    Ann Ital Chir; 2008 Oct 05; 79(2):79-80. PubMed ID: 18727268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.